scispace - formally typeset
F

Fabrizio Canonaco

Researcher at ETH Zurich

Publications -  5
Citations -  830

Fabrizio Canonaco is an academic researcher from ETH Zurich. The author has contributed to research in topics: Arginine kinase & PH reduction. The author has an hindex of 5, co-authored 5 publications receiving 765 citations.

Papers
More filters
Journal ArticleDOI

The Soluble and Membrane-bound Transhydrogenases UdhA and PntAB Have Divergent Functions in NADPH Metabolism of Escherichia coli*

TL;DR: Both transhydrogenase isoforms in E. coli have divergent physiological functions: energy-dependent reduction of NADP+ with NADH by PntAB and reoxidation of NADPH by UdhA, which raises two general questions: why do only a few bacteria contain both isoforms, and how do other organisms manage NADPH metabolism?
Journal ArticleDOI

Metabolic flux response to phosphoglucose isomerase knock-out in Escherichia coli and impact of overexpression of the soluble transhydrogenase UdhA.

TL;DR: The presented results provide first evidence that UdhA restores the cellular redox balance by catalyzing electron transfer from NADPH to NADH.
Journal ArticleDOI

Functional Expression of Phosphagen Kinase Systems Confers Resistance to Transient Stresses in Saccharomyces cerevisiae by Buffering the ATP Pool

TL;DR: The results demonstrate that temporal energy buffering is an intrinsic property of phosphagen kinases that can be transferred to phylogenetically very distant organisms.
Journal ArticleDOI

Functional expression of arginine kinase improves recovery from pH stress of Escherichia coli.

TL;DR: While wild type E. coli resumed growth after a transient pH reduction to pH 3 for 1 h with a rate that was 25% lower than before the stress, the arginine kinase expressing strain continued to grow as rapidly as before.
Journal ArticleDOI

Co-overexpression of RspAB Improves Recombinant Protein Production in Escherichia coli

TL;DR: Comparing the cellular level of three RNA polymerase sigma subunits by immunoblot analysis finds that co-overexpression of RspAB is a pertinent metabolic engineering strategy to improve recombinant protein production.